风口转移？SENS再获币圈2500万支持，大佬们为何钟情生命科技

承载着众多暴富梦想的币圈可谓是风起云涌，从6月起，先是连续暴跌的比特币粉碎了无数炒币者的信心，接着以太坊创始人之一Anthony Di Iorio宣布金盆洗手，随后各国密集出台众多针对虚拟货币的监管政策。眼看着币圈就要偃旗息鼓，马斯克近日再次为币圈站台，放言特斯拉将重新接受比特币支付。萎靡一时的币圈似乎又要支棱起来。

The circle of coins carrying a lot of rich dreams is called a windstorm, starting in June, when the successively collapsing bitcoins shattered the confidence of countless snobs, followed by the announcement by Anthony Di Iorio, one of the founding fathers of the Tahrir, of a gold bowl, followed by intensive regulatory policies against virtual currencies. Looking at the ring, the mounds are going to flinch, and the mosks are going to stand again, saying that Tesla will come back to accept bitcoins.

与此同时，处在风口浪尖的币圈大佬们似乎已经开始积极寻找下家。继以太坊创始人V神（Vitalik Buterin）向SENS研究基金会注资价值240万美元的比特币后，大佬Richard Heart也向其伸出了橄榄枝，在4天内间接向其注入超2500万美元的资金。

At the same time, it seems that the giants at the tip of the wind seem to be actively looking for their homes. Following the donation of $2.4 million in bitcoins to the Sens Research Foundation by Vitalik Buterin, the founder of the Tai family, Big Richard Heart reached out to them and indirectly injected more than $25 million in four days.

币圈大佬生物科技领域再聚首

We'll meet again in the field of biotech.

近日，HEX的创始人Richard Heart发起了一项捐赠活动。他表示，支持SENS的捐赠者可以获得与捐款额成正比。据《每日快报》报道，大批支持者在活动发起5天内就向SENS捐出了2500万美元。SENS创始人Aubrey de Gray表示基金会过往几年的年度预算都在400万美元左右，此次将有力地推动相关研究进程。

Recently, Hex’s founder, Richard Heart, launched a donation campaign. He said that donors supporting SENS could get a positive match to their contributions. According to the Daily Express, a large number of supporters donated $25 million to SENS within five days of its launch.

这并不是SENS首次与币圈牵手，前不久，V神也曾向其注资240万以支持相关研究。SENS的的主业是开发老龄伴生问题的解决方案。换句话说，SENS干的事情就是秦皇汉武追求的抗老，只不过其手段相对更加科学。V神对这一领域的关注由来已久，去年他就曾公开宣称，老去是一场不亚于二战的灾难，“所有投资都好不过抗老投资”。

In other words, what SENS does is the resistance that Qin Qin Hanwu pursues, although its methods are relatively scientific. It is a long-standing interest in this area, and last year he declared publicly that ageing was a disaster no less than World War II, and that “all investments are better than old investments.”

事实上，想在该领域分一杯羹的不仅仅是币圈。美首富贝索斯在此早有布局，他投资的Unity已于美股成功上市。而PAYPAL联合创始人彼得蒂尔一边支持着Unity，一边也向SENS抛出了橄榄枝。国内年过90的香港富豪李氏对此更为迫切，他一边支持着基因编辑，一边砸下2500万美元投资了“派维络”类物质相关企业ChromaDex......

The PAYPAL co-founder, Peter Til, supported Unity, and threw an olive branch at SENS. Hong Kong’s 90-year-old Fuzzy Lee, who supported genetic editors and invested $25 million in the “Pull Dex” material-related enterprise, Chroma Dex, was even more pressing.

干预变老或将带动数万亿美元的经济效益

Interventions grow old or will generate trillions of dollars in economic benefits

盘根错节的资本纷纷布局抗老领域，该领域的前景究竟如何呢？2019年，著名投行美银美林就曾做过一次调研分析，他们认为，该领域是未来十年最大的投资机会之一，预计到2025年市场规模将达到6000亿美元。今年7月初，伦敦商学院?Andrew Scott团队于《Nature aging》发文指出，根据经济模型测算，抗老可带动的经济效益或达数万亿美元。

In 2019, the well-known banker, Silver Merrillen, did a research study that suggested that this was one of the biggest investment opportunities in the next decade, and that the market was expected to reach $600 billion by 2025. At the beginning of July, the London Business School?

伦敦商学院的研究显示，随着生活水平的提高，人们在抗老上支出的意愿普遍有了明显的提升。遗憾的是，币圈大佬和贝索斯等富豪们钟情的前沿科技，无论是基因编辑、Unity还是SENS的研究都还处在实验室阶段，仅迫切的李嘉诚押宝的“派维络”类物质真正落地并创造了实际受益，可惜也被别人捷足先登。

Research at the London Business School shows that, with rising standards of living, people’s willingness to spend money against old age has generally increased significantly. Unfortunately, the cutting-edge technologies of rich people, such as the Money Circle and the Bethos, are still at the laboratory stage, with only the pressing “Pyclops” of Lee’s treasures actually falling into the ground and creating real benefits.

哈佛医学院、华盛顿大学、东京医学院等都曾围绕该物质展开实验，论文显示，该物质可以稳定DNA、延长端粒并拉长生存期。近期，中美日先后公布临床数据佐证该物质的效度。以东京大学的实验为例，他们让一群65岁以上的老人每日服用该物质，12周后，老人们听力和肌肉力量等指标都有了显著提升。

Harvard Medical School, Washington University, Tokyo Medical School, etc., have experimented around the substance, and papers have shown that it can stabilize DNA, extend particles, and stretch life. In recent times, China and the United States have published clinical data to support the efficacy of the substance. In the case of the Tokyo University experiment, they let a group of people over the age of 65 take the substance on a daily basis, and 12 weeks later there has been a marked increase in the hearing and muscle strength of older people.

据悉，日生科企博奥真（Bioagen）借着地利与相关机构达成合作，对该物质进行了复配，落地成果“派维络”一度成为富人圈炙手可热的“青春分子”，不仅先后被伊势丹、大丸百货等曰本本土商超引进，还通过京D国际流入了国内，创造了可观的经济效益。

According to the information received, in cooperation with the relevant institutions and with the benefit of Japan's natural resources, the substance was synthesized with the result that the local community was once a popular “young man” among the rich, and not only was over-incorporated by local businesses such as Iván, Damaru and others, but also generated considerable economic benefits through the international flow to the country through Kyoto D.

走向150岁的生命高地？

To the 150-year-old heights of life?

今年年初，国内前沿抗老科普团队复旦大学时光派曾举办过一场行业论坛，应邀参加的?Aubrey大胆预测，生物科技正呈指数级爆发，等到2036年，我们就能迎来生命长度和质量的双重飞跃。近日，新加坡与美联合发表于《Nature Communication》的论文一定程度上印证了这一说法，他们分析了544398名志愿者的医学指标后得出结论，本世纪我们将有望活到150岁。

Early this year, the front-line anti-Cop team held an invited industry forum at the University College of Revenge. Aubrey predicted that biotech was going to explode exponentially, and that by 2036 we would have a double leap in the length and quality of life. In a recent paper published jointly with the United States in Nature Corporation, Singapore and the United States, to some extent supported this statement, by analysing the medical indicators of 544398 volunteers, it was concluded that we would be able to live until the age of 150 in the century.

技术的进展似乎并没有辜负大家的期待。今年6月，先是以色列科学家宣布找到了影响小鼠生命长度的关键基因SIRT6，紧接着，靠着基因编辑斩获诺奖的詹妮弗旗下企业高调宣布其技术已在一期临床中取得积极成果。目前，全球各地都有相关实验室正积极筛选各种靶向基因，同时其他前沿技术也在紧锣密鼓地推进。

In June, Israeli scientists announced the discovery of the key gene SIRT6, which affected the length of mice’ lives, followed by a high-profile announcement by Jennifer’s Nobel Prize-winning company, that its technology had yielded positive results in a clinical phase. Currently, laboratories around the world are actively screening target-to-genesis, while other cutting-edge technologies are advancing.

或许，我们真的可以在2036年走向150岁的高地，只是不知道引领性技术是否来自大佬们钟情的SENS，谁又能从这场巨大的变革中分得最大的蛋糕。

Perhaps we can really go to the 150-year-old highlands in 2036, but we don't know if the leading technology comes from Sens, who gets the biggest share of this huge change.